Michael J. Wagner, MD

University of Washington/Fred Hutch/Seattle Cancer Care Alliance
Seattle, Washington, United States

Disclosure information not submitted.

Presentation(s):

• Paper 25 - PRELIMINARY RESULTS FROM A PHASE 1 STUDY OF FHD-609, A BROMODOMAIN-CONTAINING PROTEIN 9 DEGRADER, IN PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR SMARCB1-LOSS TUMORS

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM  

• Paper 30 - OUTCOMES OF PATIENTS WITH ADVANCED SYNOVIAL SARCOMA TREATED WITH AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")

  Friday, November 3, 2023
  9:00 AM – 10:00 AM